pLEX307-puro-SARS-CoV-2-nsp4-nsp5-nsp6
(Plasmid
#247701)
-
PurposeConstitutive expression of SARS-CoV-2 nsp5 fused to nsp4 and an N-terminal fragment of nsp6 under EF1-alpha promoter with puromycin resistance.
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 247701 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepLEX307
-
Backbone manufacturerDavid Root (Addgene #41392)
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameSARS-CoV-2 3CL protease fused to nsp4 and nsp6
-
SpeciesSARS-CoV-2
- Promoter EF1a
Cloning Information
- Cloning method Gateway Cloning
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
We have noticed that bacterial transposons commonly arise in this series of plasmids, and suggest checking the integrity of the plasmids prior to use.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLEX307-puro-SARS-CoV-2-nsp4-nsp5-nsp6 was a gift from Sho Iketani (Addgene plasmid # 247701 ; http://n2t.net/addgene:247701 ; RRID:Addgene_247701) -
For your References section:
Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors. Chithelen J, Lovett DH, Wang K, Torres Yanagisawa AE, Caccin FNM, Iketani S. Nat Commun. 2026 May 19;17(1):6575. doi: 10.1038/s41467-026-73444-y. 10.1038/s41467-026-73444-y PubMed 42156379